Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
PfizerPFE |
$440,000 |
 |
Mind Medicine (MindMed)MNMD |
-$86M |
 |
ModernaMRNA |
-$37.4B |
 |
AbbVieABBV |
-$792M |
 |
Eli Lilly and CompanyLLY |
-$334,594B |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| MORIKIS JOHN G | Nov 26, 2025 | Buy | 1,250 | $206.15 | $260,000 |
| REED JOHN C | Oct 17, 2025 | Sell | 21,721 | $192.7072 | $4.2M |
| Taubert Jennifer L | Sep 4, 2025 | Sell | 56,471 | $177.806 | $10M |
| Duato Joaquin | Aug 22, 2025 | Sell | 125,824 | $179.2079 | $23M |
| Wolk Joseph J | Aug 15, 2025 | Sell | 16,820 | $176.9067 | $3M |
| REED JOHN C | Jul 17, 2025 | Sell | 19,137 | $163.5486 | $3.1M |
| Decker Robert J | Feb 25, 2025 | Sell | 6,999 | $165.88 | $1.2M |
| Schmid Timothy | Feb 18, 2025 | Sell | 403 | $156.15 | $63,000 |
| Wolk Joseph J | Feb 7, 2025 | Sell | 13,015 | $153.89 | $2M |
| WEINBERGER MARK A | Dec 12, 2024 | Buy | 1,000 | $147.22 | $150,000 |
| Decker Robert J | Aug 30, 2024 | Sell | 5,635 | $165.06 | $930,000 |
| Woods Eugene A. | Apr 30, 2024 | Buy | 100 | $145.53 | $15,000 |
| Broadhurst Vanessa | Mar 13, 2024 | Sell | 8,891 | $162.16 | $1.4M |
| Taubert Jennifer L | Feb 9, 2024 | Sell | 59,397 | $156.27 | $9.3M |
FAQ - Insider Transactions
The most recent insider transaction for Johnson & Johnson was conducted by MORIKIS JOHN G, who sold 1,250 shares on November 26, 2025 at a price of $206.15 per share.
MORIKIS JOHN G has bought the most JNJ stock in the last 2 years, with a total value of $260,000.
Duato Joaquin has sold the most JNJ stock in the last 2 years, with a total value of $23M.
The total value of insider transactions for Johnson & Johnson in the last 2 years is negative, amounting to -$57M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
Over the last 2 years, insider transactions for Johnson & Johnson have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
